Dr. Gordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Florida Cancer Specialists (GCC)
6420 W Newberry Rd, East Wing, Suite 100
Gainesville, FL 32605Phone+1 352-332-3900Fax+1 352-332-5009
Summary
- Dr. Lucio Gordan is an oncologist in Gainesville, FL and is affiliated with North Florida Regional Medical Center. He received his medical degree from Other and has been in practice 24 years. He specializes in hematologic oncology and is experienced in hematologic oncology and general / benign hematology.
Education & Training
- University of FloridaFellowship, Hematology and Medical Oncology, 2000
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1994 - 1997
- OtherClass of 1994
Certifications & Licensure
- FL State Medical License 1997 - 2027
- UT State Medical License 2018 - 2026
- TX State Medical License 2019 - 2026
- IL State Medical License 2018 - 2026
- AZ State Medical License 2018 - 2023
- OH State Medical License 2018 - 2023
- NC State Medical License 2018 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Feb 01
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Jan 01
Publications & Presentations
PubMed
- Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.Lucio N Gordan, David Ray, Stephen C Ijioma, George Dranitsaris, Amanda Warner
Current Oncology. 2024-01-14 - 15 citationsCompromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of...Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois
JCO Oncology Practice. 2024-01-01 - 2 citationsProgression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnos...Lucio Navarro Gordan, Carlyn Rose Tan, Robert Vescio, Jing Christine Ye, Carolina Schinke
Clinical Lymphoma, Myeloma & Leukemia. 2024-01-01
Press Mentions
- NCODA Announces Lucio N. Gordan, MD, to Join Board of Directors, Enhancing Leadership in Oncology Patient-Centered CareJanuary 15th, 2025
- Florida Cancer Specialists & Research Institute Driving Patient-Centered Excellence Through Value-Based Care InitiativesJanuary 9th, 2025
- Florida Cancer Specialists & Research Institute President Invited to Speak at White House Event Celebrating Cancer Moonshot and Nationwide Efforts to End CancerJanuary 7th, 2025
- Join now to see all
Professional Memberships
- Member
Other Languages
- Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: